Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +0.46% | +11.03% | +35.48% | +0.74% | 76.75B | |
| -1.83% | -10.32% | +20.42% | +182.81% | 50.46B | |
| +1.54% | +2.37% | -6.31% | +23.71% | 48.5B | |
| +1.30% | +3.35% | -50.46% | -50.08% | 44.14B | |
| -0.17% | -1.41% | +55.23% | -23.29% | 30.53B | |
| -1.19% | -6.86% | +52.31% | +86.04% | 24.28B | |
| -4.26% | -1.16% | +96.07% | -50.22% | 22.46B | |
| +0.72% | +1.39% | -7.90% | +177.29% | 20.04B | |
| +1.13% | -5.79% | +62.11% | +120.47% | 16.14B | |
| Average | +0.49% | -0.45% | +28.55% | +51.94% | 37.03B | |
| Weighted average by Cap. | +0.42% | +1.06% | +21.53% | +41.91% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.9M 2.71M 2.48M 4.68M 318M 4.75M 31.76M 12.46M 159M 12.53M 12.26M 529M | 6.18M 5.36M 5.02M 4.59M 8.66M 588M 8.79M 58.78M 23.05M 294M 23.2M 22.7M 979M |
| Net income | 1.4M 1.22M 1.14M 1.04M 1.97M 133M 1.99M 13.34M 5.23M 66.73M 5.27M 5.15M 222M | 2.41M 2.09M 1.96M 1.79M 3.38M 229M 3.43M 22.92M 8.99M 115M 9.05M 8.85M 382M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
